Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Identifieur interne : 001150 ( Main/Curation ); précédent : 001149; suivant : 001151Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Auteurs : Carmel M. Mceniery [Royaume-Uni] ; Marie Fisk [Royaume-Uni] ; Karen Miles [Royaume-Uni] ; Fotini Kaloyirou [Royaume-Uni] ; Annette Hubsch [Royaume-Uni] ; Jane Smith [Royaume-Uni] ; Ian B. Wilkinson [Royaume-Uni] ; Joseph Cheriyan [Royaume-Uni]Source :
- Trials [ 1745-6215 ] ; 2020.
Abstract
An amendment to this paper has been published and can be accessed via the original article.
DOI: 10.1186/s13063-020-04578-7
PubMed: 32665001
PubMed Central: PMC7358337
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001150
Links to Exploration step
pubmed:32665001Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.</title>
<author><name sortKey="Mceniery, Carmel M" sort="Mceniery, Carmel M" uniqKey="Mceniery C" first="Carmel M" last="Mceniery">Carmel M. Mceniery</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fisk, Marie" sort="Fisk, Marie" uniqKey="Fisk M" first="Marie" last="Fisk">Marie Fisk</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Miles, Karen" sort="Miles, Karen" uniqKey="Miles K" first="Karen" last="Miles">Karen Miles</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kaloyirou, Fotini" sort="Kaloyirou, Fotini" uniqKey="Kaloyirou F" first="Fotini" last="Kaloyirou">Fotini Kaloyirou</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hubsch, Annette" sort="Hubsch, Annette" uniqKey="Hubsch A" first="Annette" last="Hubsch">Annette Hubsch</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Smith, Jane" sort="Smith, Jane" uniqKey="Smith J" first="Jane" last="Smith">Jane Smith</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wilkinson, Ian B" sort="Wilkinson, Ian B" uniqKey="Wilkinson I" first="Ian B" last="Wilkinson">Ian B. Wilkinson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cheriyan, Joseph" sort="Cheriyan, Joseph" uniqKey="Cheriyan J" first="Joseph" last="Cheriyan">Joseph Cheriyan</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32665001</idno>
<idno type="pmid">32665001</idno>
<idno type="doi">10.1186/s13063-020-04578-7</idno>
<idno type="pmc">PMC7358337</idno>
<idno type="wicri:Area/Main/Corpus">001150</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001150</idno>
<idno type="wicri:Area/Main/Curation">001150</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001150</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.</title>
<author><name sortKey="Mceniery, Carmel M" sort="Mceniery, Carmel M" uniqKey="Mceniery C" first="Carmel M" last="Mceniery">Carmel M. Mceniery</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fisk, Marie" sort="Fisk, Marie" uniqKey="Fisk M" first="Marie" last="Fisk">Marie Fisk</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Miles, Karen" sort="Miles, Karen" uniqKey="Miles K" first="Karen" last="Miles">Karen Miles</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kaloyirou, Fotini" sort="Kaloyirou, Fotini" uniqKey="Kaloyirou F" first="Fotini" last="Kaloyirou">Fotini Kaloyirou</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hubsch, Annette" sort="Hubsch, Annette" uniqKey="Hubsch A" first="Annette" last="Hubsch">Annette Hubsch</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Smith, Jane" sort="Smith, Jane" uniqKey="Smith J" first="Jane" last="Smith">Jane Smith</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wilkinson, Ian B" sort="Wilkinson, Ian B" uniqKey="Wilkinson I" first="Ian B" last="Wilkinson">Ian B. Wilkinson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cheriyan, Joseph" sort="Cheriyan, Joseph" uniqKey="Cheriyan J" first="Joseph" last="Cheriyan">Joseph Cheriyan</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Trials</title>
<idno type="eISSN">1745-6215</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">An amendment to this paper has been published and can be accessed via the original article.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32665001</PMID>
<DateRevised><Year>2020</Year>
<Month>07</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>21</Volume>
<Issue>1</Issue>
<PubDate><Year>2020</Year>
<Month>07</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>Trials</Title>
<ISOAbbreviation>Trials</ISOAbbreviation>
</Journal>
<ArticleTitle>Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.</ArticleTitle>
<Pagination><MedlinePgn>641</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-020-04578-7</ELocationID>
<Abstract><AbstractText>An amendment to this paper has been published and can be accessed via the original article.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McEniery</LastName>
<ForeName>Carmel M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fisk</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK. mf503@medschl.cam.ac.uk.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK. mf503@medschl.cam.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Miles</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kaloyirou</LastName>
<ForeName>Fotini</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hubsch</LastName>
<ForeName>Annette</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Smith</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wilkinson</LastName>
<ForeName>Ian B</ForeName>
<Initials>IB</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cheriyan</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016425">Published Erratum</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Trials</MedlineTA>
<NlmUniqueID>101263253</NlmUniqueID>
<ISSNLinking>1745-6215</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Trials. 2020 Jul 2;21(1):604</RefSource>
<PMID Version="1">32616067</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32665001</ArticleId>
<ArticleId IdType="doi">10.1186/s13063-020-04578-7</ArticleId>
<ArticleId IdType="pii">10.1186/s13063-020-04578-7</ArticleId>
<ArticleId IdType="pmc">PMC7358337</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Trials. 2020 Jul 2;21(1):604</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32616067</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001150 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001150 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:32665001 |texte= Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:32665001" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |